Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry

Robert P. Baughman, Oksana A. Shlobin, Athol U. Wells, Esam H. Alhamad, Daniel A. Culver, Joseph Barney, Francis C. Cordova, Eva M. Carmona, Mary Beth Scholand, Marlies Wijsenbeek, Sivagini Ganesh, Surinder S. Birring, Vasilis Kouranos, Lanier O'Hare, Joanne M. Baran, Joseph G. Cal, Elyse E. Lower, Peter J. Engel, Steven D. Nathan

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Background: Pulmonary hypertension (PH) is a significant cause of morbidity and mortality in sarcoidosis. We established a multi-national registry of sarcoidosis associated PH (SAPH) patients. Methods: Sarcoidosis patients with PH confirmed by right heart catheterization (RHC) were studied. Patients with pulmonary artery wedge pressure (PAWP) of 15 mmHg or less and a mean pulmonary artery pressure (mPAP) ≥ 25 Hg were subsequently analyzed. Data collected included hemodynamics, forced vital capacity (FVC), diffusion capacity of carbon monoxide (DLCO), chest x-ray, and 6-min walk distance (6MWD). Results: A total of 176 patients were analyzed. This included 84 (48%) cases identified within a year of entry into the registry and 94 (53%) with moderate to severe PH. There was a significant correlation between DLCO percent predicted (% pred) andmPAP (Rho = −0.228, p = 0.0068) and pulmonary vascular resistance (PVR) (Rho = −0.362, p < 0.0001). PVR was significantly higher in stage 4 disease than in stage 0 or 1 disease (p < 0.05 for both comparisons). About two-thirds of the SAPH patients came from the United States (US). There was a significant difference in the rate of treatment between US (67.5%) versus non-US (86%) (Chi Square 11.26, p = 0.0008) sites. Conclusions: The clinical features of SAPH were similar across multiple centers in the US, Europe, and the Middle East. The severity of SAPH was related to reduced DLCO. There were treatment differences between the US and non-US centers.

Original languageEnglish (US)
Pages (from-to)72-78
Number of pages7
JournalRespiratory Medicine
Volume139
DOIs
StatePublished - Jun 2018

Keywords

  • Epidemiology
  • Sarcoidosis
  • Sarcoidosis associated pulmonary hypertension

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry'. Together they form a unique fingerprint.

  • Cite this

    Baughman, R. P., Shlobin, O. A., Wells, A. U., Alhamad, E. H., Culver, D. A., Barney, J., Cordova, F. C., Carmona, E. M., Scholand, M. B., Wijsenbeek, M., Ganesh, S., Birring, S. S., Kouranos, V., O'Hare, L., Baran, J. M., Cal, J. G., Lower, E. E., Engel, P. J., & Nathan, S. D. (2018). Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Respiratory Medicine, 139, 72-78. https://doi.org/10.1016/j.rmed.2018.04.015